Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

MLA

Werth, Victoria P., et al. “Multicenter Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris.” Archives of Dermatology, vol. 144, no. 1, Jan. 2008, pp. 25–32. EBSCOhost, https://doi.org/10.1001/archderm.144.1.25.

APA

Werth, V. P., Fivenson, D., Pandya, A. G., Chen, D., Rico, M. J., Albrecht, J., & Jacobus, D. (2008). Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Archives of Dermatology, 144(1), 25–32. https://doi.org/10.1001/archderm.144.1.25

Chicago

Werth, Victoria P, David Fivenson, Amit G Pandya, Diana Chen, M Joyce Rico, Joerg Albrecht, and David Jacobus. 2008. “Multicenter Randomized, Double-Blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris.” Archives of Dermatology 144 (1): 25–32. doi:10.1001/archderm.144.1.25.